Search clinical trials for: Sitagliptin placebo
Total 53957 results
-
EMSNot yet recruitingType 2 Diabetes Mellitus
-
Icahn School of Medicine at Mount SinaiNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Withdrawn
-
Merck Sharp & Dohme LLCCompleted
-
Michael A. NauckCompleted
-
TakedaCompletedDiabetes MellitusUnited States, Mexico
-
Garvan Institute of Medical ResearchCompleted
-
Johns Hopkins UniversityMerck Sharp & Dohme LLCTerminatedGlucose HomeostasisUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Royal Adelaide HospitalMerck Sharp & Dohme LLCCompletedDiabetes Mellitus | GastroparesisAustralia
-
Samuel Lunenfeld Research Institute, Mount Sinai...Merck Sharp & Dohme LLCCompleted
-
BiogenCompletedAcute Ischemic StrokeSpain, United States, Germany
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Belgium, Canada, France, India, Italy, Korea, Republic of, Malaysia, Netherlands, Spain
-
University of PisaMerck Sharp & Dohme LLCCompleted
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Korea, Republic of, Latvia, Peru, Lithuania, Israel, Norway, Finland, Argentina, Austria, Belgium, Germany, Greece, Guatemala, Hungary, India, Italy, Mexico, Poland, Romania, Slovakia, Venezuela
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Singapore
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2Germany, United States, France, United Kingdom
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Ono Pharmaceutical Co. LtdCompletedType 2 Diabetes MellitusJapan
-
Merck Sharp & Dohme LLCTerminated
-
University of VermontCompletedImpaired Glucose Tolerance | Pre-diabetes | Impaired Fasting GlucoseUnited States
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Mexico, India
-
Istanbul UniversityNestléCompleted
-
Novartis PharmaceuticalsCompleted
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States
-
Novartis PharmaceuticalsWithdrawn
-
University of Southern CaliforniaCompletedInflammation | AtherosclerosisUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Medical College of WisconsinMerck Sharp & Dohme LLCCompletedDiabetes | AtherosclerosisUnited States
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
Merck Sharp & Dohme LLCCompleted
-
Royal Adelaide HospitalCompletedDiabetes Mellitus | GastroparesisAustralia
-
Merck Sharp & Dohme LLCCompleted
-
Wolfgang-Michael FranzWithdrawn
-
Hvidovre University HospitalUniversity of CopenhagenCompletedSevere ObesityDenmark
-
Dawn Smiley MDCompletedHyperglycemia | Ketosis Prone Diabetes | Diabetes KetoacidosisUnited States
-
Boehringer IngelheimEli Lilly and CompanyWithdrawnDiabetes Mellitus, Type 2
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
vTv TherapeuticsCompleted
-
AstraZenecaCompleted
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2Spain, United Kingdom, United States, France
-
Merck Sharp & Dohme LLCCompletedDiabetes Mellitus, Type 2
-
Ludwig-Maximilians - University of MunichMerck Sharp & Dohme LLCCompletedType 2 Diabetes MellitusGermany
-
Vanderbilt University Medical CenterAmerican Heart AssociationCompleted
-
University of ArkansasUniversity Hospital, Geneva; Université de MontréalTerminatedHepatic Encephalopathy | Cirrhosis | Refractory Ascites | Hepatic HydrothoraxUnited States, Canada, Switzerland
-
Johnson & Johnson Consumer and Personal Products...CompletedAndrogenetic AlopeciaUnited States